Home > Products
Cat. No. Product name CAS No.
DC66634 R707 Featured

DC66635 ofatumumab Featured

Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes.

679818-59-8
DC66636 Genefrontier patent anti-CD69 Featured

DC66637 KHK-2898 Featured

DC66638 CergutuzumAb Featured

DC66639 Class III Featured

DC66640 IMAB027 Featured

IMAB027 (ASP1650) is a specific anti-CLDN6 mAb, while CLDN6 (Claudin 6) is a tight junction membrane protein, aberrantly expressed in various human cancer types, ovarian cancers particularly. IMAB 027 shows anti-tumor activity, and induces apoptosis in CLDN6+ ovarian and testicular cancer cell lines.

1650599-68-0
DC66641 AB1-11 Featured

DC66642 IM-301 Featured

DC66643 lendalizumab Featured

DC66644 Nurulimab Featured

Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma.

2168561-20-2
DC66645 Epilactose Featured

50468-56-9
DC66646 Dinotefuran UF Featured

Dinotefuran UF is the deuterium labeled γ-Tocotrienol. γ-Tocotrienol is an active form of vitamin E

457614-34-5
DC66647 ICA-1S Featured

ICA-1S is a potent, specific inhibitor of Protein Kinase C-iota (PKC-ι), does not inhibit PKC-ζ, the closely related atypical PKC family member.

90597-15-2
DC60638 Acid-degradable PEG Lipid (ADP-2k) Featured

Acid-degradable PEG Lipid (ADP) composed of polyethylene glycol lipid is synthesized with the azido-acetal linker and used to generate RD-LNPs, which significantly improves the performance of LNP-mRNA complexes in vitro and in vivo.

DC60639 Acid-degradable Anionic Lipid (ADA) Featured

Acid-degradable Anionic Lipid (ADA) composed of anionic lipid is synthesized with the azido-acetal linker and used to generate RD-LNPs, which significantly improves the performance of LNP-mRNA complexes in vitro and in vivo.

DC60640 LI-3948 Featured

LI-3948 is a blood-brain barrier penetrant inositol hexakisphosphate kinase (IP6K) inhibitor with IC50 of 16 nM and brain/plasma ratio of 1.3, respectively.

DC66648 CP-LC-1143 Featured

Lipid CP-LC-1143 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity.

3040859-45-5
DC66649 CP-LC-1254 Featured

Lipid CP-LC-1254 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity.

3040859-52-4
DC66650 CP-LC-0729 Featured

Lipid CP-LC-0729 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity.

3040858-60-1
DC66651 CP-LC-0743 Featured

Lipid CP-LC-0743 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity.

3040858-73-6
DC66652 CP-LC-0867 Featured

Lipid CP-LC-0867 is an ionizable cationic amino lipid derived from homocysteine, a naturally occurring amino acid. This lipid has demonstrated an efficient delivery and high protein expression of different kinds of RNA (mRNA, cRNA and saRNA) in vivo, with no signs of toxicity.

3040858-96-3
Page 1900 / Total 1920 FirstPrevNextLastGoto